Vitamin Shoppe estimates and price target raised at JPMorgan JPMorgan believes Vitamin Shoppe's acceleration in footage growth and improvements in merchandising has made the company's story more compelling. The firm raised its 2013 earnings estimates above consensus and upped its price target for shares to $73 from $69 while keeping an Overweight rating on the stock.
News For VSI From The Last 14 Days
Check below for free stories on VSI the last two weeks.
GNC Holdings upgraded to Outperform from Neutral at Credit Suisse Credit Suisse upgraded GNC Holdings (GNC) to Outperform citing valuation, its positive view of new CEO Michael Archbold, and the potential for an accretive acquisition of Vitamin Shoppe (VSI). The firm keeps a $43 price target for shares.